{"DataElement":{"publicId":"4787952","version":"1","preferredName":"Acute Lymphoblastic Leukemia Molecular Pathology Subtype","preferredDefinition":"Text term that represents the kind of sentinel chromosome translocation or molecular lesion.","longName":"4787178v1.0:4787214v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"4787178","version":"1","preferredName":"Acute Lymphoblastic Leukemia Molecular Pathology Subtype","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._Description of disease and disease processes based upon the underlying protein and genetic defects rather than by a description of morphology._A group forming a type within a larger type.","longName":"2674126v1.0:4787176v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2674126","version":"1","preferredName":"ALL","preferredDefinition":"A leukemia with an acute onset, characterized by the presence of lymphoblasts or Burkitt cells in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia, precursor T lymphoblastic leukemia, and Burkitt's leukemia.","longName":"C3167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3834F55C-324A-1EBE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-21","modifiedBy":"ONEDATA","dateModified":"2007-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4787176","version":"1","preferredName":"Molecular Pathology Subtype","preferredDefinition":"Description of disease and disease processes based upon the underlying protein and genetic defects rather than by a description of morphology.:A group forming a type within a larger type.","longName":"C18098:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Pathology","conceptCode":"C18098","definition":"Description of disease and disease processes based upon the underlying protein and genetic defects rather than by a description of morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1350C988-EA86-C843-E050-BB89AD433D84","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1350C988-EA97-C843-E050-BB89AD433D84","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 4/9/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4787214","version":"1","preferredName":"ALL Molecular Type","preferredDefinition":"The kind of sentinel chromosome translocation or molecular lesion.","longName":"4787214v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BE90-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BE9A-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Hypodiploid <44 chromosomes","valueDescription":"Hypodiploid B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4787216","version":"1","preferredName":"Hypodiploid B Acute Lymphoblastic Leukemia","longName":"4787216","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts which contain less than 46 chromosomes. It occurs in both children and adults. It has an unfavorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypodiploid B Acute Lymphoblastic Leukemia","conceptCode":"C80345","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts which contain less than 46 chromosomes. It occurs in both children and adults. It has an unfavorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BEA7-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BEC0-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"ERG deregulated","valueDescription":"ERG Deregulation","ValueMeaning":{"publicId":"4787217","version":"1","preferredName":"ERG Deregulation","longName":"4787217","preferredDefinition":"A molecular genetic abnormality indicating deregulation of the ERG oncogene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERG Deregulation","conceptCode":"C121534","definition":"A molecular genetic abnormality indicating deregulation of the ERG oncogene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BECC-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BEE5-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"T-cell ALL","valueDescription":"T Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4263973","version":"1","preferredName":"T Acute Lymphoblastic Leukemia","longName":"4263973","preferredDefinition":"Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T Acute Lymphoblastic Leukemia","conceptCode":"C3183","definition":"Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1133-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BEF9-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"MLL rearranged","valueDescription":"B Acute Lymphoblastic Leukemia with t(v;11q23); MLL Rearranged","ValueMeaning":{"publicId":"3935835","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with t(v;11q23); MLL Rearranged","longName":"3935835","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the MLL gene at 11q23 and another gene partner resulting in the production of an MLL related fusion protein.  It is the most commonly seen leukemia in the pediatric population under the age of one year. The prognosis is unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged","conceptCode":"C80342","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of an KMT2A related fusion protein. It is the most commonly seen leukemia in the pediatric population under the age of one year. The prognosis is unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-29B2-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BF0D-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"BCR-ABL1","valueDescription":"B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1","ValueMeaning":{"publicId":"4787219","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1","longName":"4787219","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1","conceptCode":"C36312","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BF1A-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BF33-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"CRLF2-rearranged","valueDescription":"IGH/CRLF2 Fusion Gene","ValueMeaning":{"publicId":"4170676","version":"1","preferredName":"IGH/CRLF2 Fusion Gene","longName":"4170676","preferredDefinition":"A fusion gene that results from a chromosomal translocation, either t(X;14)(p22;q32) or t(Y;14)(p11;q32), which fuses the transcriptional enhancers of the IGH gene locus with regulatory regions of the CRLF2 gene. This rearrangement is associated with acute lymphoblastic leukemia and expression of this fusion gene results in overexpression of the cytokine receptor-like factor 2 protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IGH/CRLF2 Fusion Gene","conceptCode":"C113512","definition":"A fusion gene that results from a chromosomal translocation, either t(X;14)(p22;q32) or t(Y;14)(p11;q32), which fuses the transcriptional enhancers of the IGH gene locus with regulatory regions of the CRLF2 gene. This rearrangement is associated with acute lymphoblastic leukemia and expression of this fusion gene results in overexpression of the cytokine receptor-like factor 2 protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3284812-BC9B-82AE-E040-BB89AD4328E1","latestVersionIndicator":"Yes","beginDate":"2014-02-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-02-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BF47-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"TCF3-HLF","valueDescription":"TCF3/HLF Fusion Gene","ValueMeaning":{"publicId":"4787221","version":"1","preferredName":"TCF3/HLF Fusion Gene","longName":"4787221","preferredDefinition":"A fusion gene (~4.4 kb) that results from a chromosomal translocation t(17;19)(q22;p13) which fuses intron 13 of the TCF3 gene with intron 3 of the HLF gene. This rearrangement is associated with childhood pre-B cell acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TCF3/HLF Fusion Gene","conceptCode":"C99289","definition":"A fusion gene (~4.4 kb) that results from a chromosomal translocation t(17;19)(q22;p13) which fuses intron 13 of the TCF3 gene with intron 3 of the HLF gene. This rearrangement is associated with childhood pre-B cell acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BF55-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BF6E-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"TCF3-PBX1","valueDescription":"B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)","ValueMeaning":{"publicId":"3965205","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)","longName":"3965205","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1. It occurs in children and less often in adults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1","conceptCode":"C80347","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1. It occurs in children and less often in adults.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC17A880-BA3E-B6FA-E040-BB89AD436BDB","latestVersionIndicator":"Yes","beginDate":"2013-11-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BF82-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"ETV6-RUNX1","valueDescription":"B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)","ValueMeaning":{"publicId":"4787223","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)","longName":"4787223","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It is commonly seen in children and rarely in adults. It has a favorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1","conceptCode":"C80343","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It is commonly seen in children and rarely in adults. It has a favorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BF8F-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"MAESKEB","dateModified":"2021-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BFA8-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Trisomy of both chromosomes 4 and 10","valueDescription":"Simultaneous Trisomies of Chromosomes 4 and 10","ValueMeaning":{"publicId":"4787224","version":"1","preferredName":"Simultaneous Trisomies of Chromosomes 4 and 10","longName":"4787224","preferredDefinition":"The concurrent presence of three copies each of chromosomes 4 and 10.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Simultaneous Trisomies of Chromosomes 4 and 10","conceptCode":"C96481","definition":"The concurrent presence of three copies each of chromosomes 4 and 10.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BFB4-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BFCD-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Hyperdiploidy without trisomy of both chromosomes 4 and 10","valueDescription":"Hyperdiploid B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4787226","version":"1","preferredName":"Hyperdiploid B Acute Lymphoblastic Leukemia","longName":"4787226","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It is commonly seen in children and rarely in adults. It has a favorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperdiploid B Acute Lymphoblastic Leukemia","conceptCode":"C80344","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It is commonly seen in children and rarely in adults. It has a favorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BFDA-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13512EE0-BFF3-F3CD-E050-BB89AD432E2B","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"iAMP21","valueDescription":"Intrachromosomal Amplification of Chromosome 21","ValueMeaning":{"publicId":"5094536","version":"1","preferredName":"Intrachromosomal Amplification of Chromosome 21","longName":"5094536","preferredDefinition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrachromosomal Amplification of Chromosome 21","conceptCode":"C124874","definition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2796F431-2C90-87F5-E050-BB89AD43578E","latestVersionIndicator":"Yes","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2796F431-2CA9-87F5-E050-BB89AD43578E","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"ONEDATA","dateModified":"2015-12-23","deletedIndicator":"No"},{"value":"Hyperdiploid; status of 4 and 10 unknown","valueDescription":"Hyperdiploid with Status of Chromosomes 4 and 10 Unknown","ValueMeaning":{"publicId":"5094537","version":"1","preferredName":"Hyperdiploid with Status of Chromosomes 4 and 10 Unknown","longName":"5094537","preferredDefinition":"Having a chromosomal number greater than the normal diploid number, with the status of chromosomes 4 and 10 unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperdiploid with Status of Chromosomes 4 and 10 Unknown","conceptCode":"C124873","definition":"Having a chromosomal number greater than the normal diploid number, with the status of chromosomes 4 and 10 unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2796F431-2CB5-87F5-E050-BB89AD43578E","latestVersionIndicator":"Yes","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2796F431-2CCE-87F5-E050-BB89AD43578E","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"ONEDATA","dateModified":"2015-12-23","deletedIndicator":"No"},{"value":"Hypodiploid","valueDescription":"Hypodiploidy","ValueMeaning":{"publicId":"3927272","version":"1","preferredName":"Hypodiploidy","longName":"3927272","preferredDefinition":"A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypodiploidy","conceptCode":"C80337","definition":"A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9689178-AC4E-B27C-E040-BB89AD4313AB","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2796F431-2CE2-87F5-E050-BB89AD43578E","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"ONEDATA","dateModified":"2015-12-23","deletedIndicator":"No"},{"value":"NUP-ABL1 (T cell)","valueDescription":"NUP214/ABL1 Fusion Gene","ValueMeaning":{"publicId":"7652500","version":"1","preferredName":"NUP214/ABL1 Fusion Gene","longName":"7652500","preferredDefinition":"A fusion gene that results from a chromosomal rearrangement of 9q34 which fuses almost all or the 5' half of the NUP214 gene with intron 1 of the ABL1 gene. This fusion is associated with T-cell acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NUP214/ABL1 Fusion Gene","conceptCode":"C179232","definition":"A fusion gene that results from a chromosomal rearrangement of 9q34 which fuses almost all or the 5' half of the NUP214 gene with intron 1 of the ABL1 gene. This fusion is associated with T-cell acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AD68DF-F7D6-04DA-E053-4EBD850AB0B3","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-06","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AD68DF-F7EF-04DA-E053-4EBD850AB0B3","beginDate":"2021-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"KMT2Ar","valueDescription":"MLL Gene Rearrangement","ValueMeaning":{"publicId":"5540277","version":"1","preferredName":"MLL Gene Rearrangement","longName":"5540277","preferredDefinition":"A molecular abnormality indicating rearrangement of the MLL (KMT2A) gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KMT2A Gene Rearrangement","conceptCode":"C122623","definition":"A molecular abnormality indicating rearrangement of the KMT2A (MLL) gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FA1F895-F0FB-05B5-E053-F662850AA504","latestVersionIndicator":"Yes","beginDate":"2016-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AD68DF-F803-04DA-E053-4EBD850AB0B3","beginDate":"2021-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"TCF3-PBX1 t(1;19)","valueDescription":"t(1;19)(q23;p13.3)","ValueMeaning":{"publicId":"2672732","version":"1","preferredName":"t(1;19)(q23;p13.3)","longName":"2672732","preferredDefinition":"A chromosomal abnormality consisting of the translocation of 19p13.3 with 1q23, resulting in the fusion of the TCF3 (E2A) gene with the PBX1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;19)(q23;p13.3)","conceptCode":"C27715","definition":"A chromosomal abnormality consisting of the translocation of 19p13.3 with 1q23, resulting in the fusion of the TCF3 (E2A) gene with the PBX1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37BCDCA9-0A8F-297B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-15","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AD68DF-F818-04DA-E053-4EBD850AB0B3","beginDate":"2021-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Double Trisomy 4, 10","valueDescription":"Simultaneous Trisomies of Chromosomes 4 and 10","ValueMeaning":{"publicId":"4787224","version":"1","preferredName":"Simultaneous Trisomies of Chromosomes 4 and 10","longName":"4787224","preferredDefinition":"The concurrent presence of three copies each of chromosomes 4 and 10.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Simultaneous Trisomies of Chromosomes 4 and 10","conceptCode":"C96481","definition":"The concurrent presence of three copies each of chromosomes 4 and 10.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BFB4-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AD68DF-F82C-04DA-E053-4EBD850AB0B3","beginDate":"2021-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"BCR/ABL1","valueDescription":"BCR-ABL Oncoprotein","ValueMeaning":{"publicId":"2761451","version":"1","preferredName":"BCR-ABL Oncoprotein","longName":"2761451","preferredDefinition":"A fusion protein encoded by the BCR/ABL1 fusion gene. This protein is comprised of the N-terminus of the breakpoint cluster region protein fused to almost the entire tyrosine-protein kinase ABL1 protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Protein","conceptCode":"C16325","definition":"A fusion protein encoded by the BCR/ABL1 fusion gene. This protein is comprised of the N-terminus of the breakpoint cluster region protein fused to almost the entire tyrosine-protein kinase ABL1 protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50E2BA6A-557D-6718-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-06-30","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E20D99-4EA1-2874-E053-4EBD850ACE1D","beginDate":"2021-04-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"Hypodiploidy","valueDescription":"Hypodiploidy","ValueMeaning":{"publicId":"3927272","version":"1","preferredName":"Hypodiploidy","longName":"3927272","preferredDefinition":"A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypodiploidy","conceptCode":"C80337","definition":"A chromosomal abnormality in which the chromosomal number is less than the normal diploid number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9689178-AC4E-B27C-E040-BB89AD4313AB","latestVersionIndicator":"Yes","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E20D99-4EAC-2874-E053-4EBD850ACE1D","beginDate":"2021-04-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"Ph-like JAK STAT class","valueDescription":"Activating JAK-STAT Pathway Positive Ph-Like B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"7658112","version":"1","preferredName":"Activating JAK-STAT Pathway Positive Ph-Like B Acute Lymphoblastic Leukemia","longName":"7658112","preferredDefinition":"A finding indicating that JAK-STAT pathway activating mutations or rearrangements have been detected in a patient with Ph-like B acute lymphoblastic leukemia. This finding is associated with a higher relapse risk and may amenable to treatment that utilizes JAK-STAT pathway inhibitors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating JAK-STAT Pathway Positive Ph-Like B Acute Lymphoblastic Leukemia","conceptCode":"C179416","definition":"A finding indicating that JAK-STAT pathway activating mutations or rearrangements have been detected in a patient with Ph-like B acute lymphoblastic leukemia. This finding is associated with a higher relapse risk and may amenable to treatment that utilizes JAK-STAT pathway inhibitors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C238BA87-462B-0159-E053-4EBD850A0833","latestVersionIndicator":"Yes","beginDate":"2021-05-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-13","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C238BA87-4644-0159-E053-4EBD850A0833","beginDate":"2021-05-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-13","modifiedBy":"ONEDATA","dateModified":"2021-05-13","deletedIndicator":"No"},{"value":"Ph-like ABL class","valueDescription":"ABL Class Rearrangement Positive Ph-Like B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"7658113","version":"1","preferredName":"ABL Class Rearrangement Positive Ph-Like B Acute Lymphoblastic Leukemia","longName":"7658113","preferredDefinition":"A finding indicating that activating rearrangements of an ABL class receptor tyrosine kinase gene (which includes ABL1, ABL2, PDGFRB, and CSF1R) have been detected in a patient with Ph-like B acute lymphoblastic leukemia. This finding is associated with a higher relapse risk and may be amenable to treatment that utilizes tyrosine kinase inhibitors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ABL Class Rearrangement Positive Ph-Like B Acute Lymphoblastic Leukemia","conceptCode":"C179414","definition":"A finding indicating that activating rearrangements of an ABL class tyrosine kinase gene (which includes ABL1, ABL2, PDGFRB, and CSF1R) have been detected in a patient with Ph-like B acute lymphoblastic leukemia. This finding is associated with a higher relapse risk and may be amenable to treatment that utilizes tyrosine kinase inhibitors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C238BA87-4650-0159-E053-4EBD850A0833","latestVersionIndicator":"Yes","beginDate":"2021-05-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-13","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C238BA87-4669-0159-E053-4EBD850A0833","beginDate":"2021-05-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-05-13","modifiedBy":"ONEDATA","dateModified":"2021-05-13","deletedIndicator":"No"},{"value":"BCR/ABL1 fusion","valueDescription":null,"ValueMeaning":{"publicId":"3935833","version":"1","preferredName":"BCR/ABL1 Fusion Gene","longName":"3935833","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-298C-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E2340-683E-61AE-E053-731AD00A6EC3","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"BCR-ABL1-like features","valueDescription":null,"ValueMeaning":{"publicId":"4787966","version":"1","preferredName":"Ph-like","longName":"4787966","preferredDefinition":"A leukemia subtype characterized by a gene-expression profile similar to that of BCR-ABL1-positive acute lymphoblastic leukemia, alterations of lymphoid transcription factor genes, and a poor outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like","conceptCode":"C121974","definition":"B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of BCR-ABL1-positive B acute lymphoblastic leukemia, absence of the pathognomonic BCR-ABL1 rearrangement, alterations of lymphoid transcription factor genes, and a poor outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135EEC98-D8AD-84BF-E050-BB89AD436F63","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-10","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E28C7-F1D7-622E-E053-731AD00AE694","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"ETV6/RUNX1 fusion","valueDescription":null,"ValueMeaning":{"publicId":"2761450","version":"1","preferredName":"TEL-AML1 Oncogene","longName":"2761450","preferredDefinition":"The result of a t(12;21) translocation, TEL-AML1 Oncogene encodes a fusion protein containing the helix-loop-helix domain of TEL, a member of the ETS-like family of transcription factors, and the DNA-binding and transactivation domains of the transcription factor AML1. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ETV6/RUNX1 Fusion Gene","conceptCode":"C18517","definition":"A fusion gene that results from a chromosomal translocation t(12;21)(p13;q22) which fuses intron 5 of the ETV6 gene with intron 2 of the RUNX1 gene. This gene fusion is associated with B-cell lymphoblastic leukemia/lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50E2BA6A-5558-6718-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-06-30","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E2CBE-D8B0-627C-E053-731AD00A5651","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"High hyperdiploidy","valueDescription":null,"ValueMeaning":{"publicId":"5574403","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy","longName":"5574403","preferredDefinition":"A precursor lymphoid neoplasm composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It has a favorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperdiploid B Lymphoblastic Leukemia/Lymphoma","conceptCode":"C80335","definition":"A precursor lymphoid neoplasm composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It has a favorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-76BA-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E355C-37F9-636A-E053-731AD00AB10D","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"IGH-IL3 fusion","valueDescription":null,"ValueMeaning":{"publicId":"3935832","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH","longName":"3935832","preferredDefinition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). It results in eosinophilia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH","conceptCode":"C80340","definition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). It results in eosinophilia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-2953-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":"Updated definition and VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E3950-AA27-63FA-E053-731AD00AEF6C","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"MYC rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"5782793","version":"1","preferredName":"MYC Gene Rearrangement","longName":"5782793","preferredDefinition":"A molecular abnormality indicating rearrangement of the MYC gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYC Gene Rearrangement","conceptCode":"C132018","definition":"A molecular abnormality indicating rearrangement of the MYC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E26C073-62E2-0E10-E053-F662850AB15D","latestVersionIndicator":"Yes","beginDate":"2017-04-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-04-27","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E3F5E-8FD0-64A2-E053-731AD00A5741","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"NUTM1 rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"6386932","version":"1","preferredName":"NUTM1 Gene Rearrangement","longName":"6386932","preferredDefinition":"A molecular abnormality indicating rearrangement of the NUTM1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NUTM1 Gene Rearrangement","conceptCode":"C153269","definition":"A molecular abnormality indicating rearrangement of the NUTM1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72F686B3-1FF0-7C94-E053-F662850AFAFB","latestVersionIndicator":"Yes","beginDate":"2018-08-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-08-09","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E3F5E-8FD1-64A2-E053-731AD00A5741","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"PAX5 p.P80R","valueDescription":null,"ValueMeaning":{"publicId":"12114312","version":"1","preferredName":"PAX5 NP_057953.1:p.P80R","longName":"12114312v1.00","preferredDefinition":"A change in the amino acid residue at position 80 in paired box protein Pax-5 where proline has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PAX5 NP_057953.1:p.P80R","conceptCode":"C158142","definition":"A change in the amino acid residue at position 80 in paired box protein Pax-5 where proline has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8E4456-3E82-6543-E053-731AD00AA2B4","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E4456-3E83-6543-E053-731AD00AA2B4","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"TCF3/PBX1 fusion","valueDescription":null,"ValueMeaning":{"publicId":"3698372","version":"1","preferredName":"TCF3/PBX1 Fusion Gene","longName":"3698372","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(1;19)(q23;p13) which fuses intron 13 of the TCF3 gene with exon 2 of the PBX1 gene. This rearrangement is associated with pre-B cell acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TCF3/PBX1 Fusion Gene","conceptCode":"C99291","definition":"A fusion gene that results from a chromosomal translocation t(1;19)(q23;p13) which fuses intron 13 of the TCF3 gene with exon 2 of the PBX1 gene. This rearrangement is associated with pre-B cell acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D827A30E-439A-CEC8-E040-BB89AD434B61","latestVersionIndicator":"Yes","beginDate":"2013-03-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-03-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E49EE-EA2C-65D5-E053-731AD00ADB17","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"TCF3/HLF fusion","valueDescription":null,"ValueMeaning":{"publicId":"4787221","version":"1","preferredName":"TCF3/HLF Fusion Gene","longName":"4787221","preferredDefinition":"A fusion gene (~4.4 kb) that results from a chromosomal translocation t(17;19)(q22;p13) which fuses intron 13 of the TCF3 gene with intron 3 of the HLF gene. This rearrangement is associated with childhood pre-B cell acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TCF3/HLF Fusion Gene","conceptCode":"C99289","definition":"A fusion gene (~4.4 kb) that results from a chromosomal translocation t(17;19)(q22;p13) which fuses intron 13 of the TCF3 gene with intron 3 of the HLF gene. This rearrangement is associated with childhood pre-B cell acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BF55-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E49EE-EA2D-65D5-E053-731AD00ADB17","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"ZNF384 rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"12114313","version":"1","preferredName":"ZNF384 Gene Rearrangement","longName":"12114313v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the ZNF384 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ZNF384 Gene Rearrangement","conceptCode":"C187018","definition":"A molecular abnormality indicating rearrangement of the ZNF384 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8E5201-BC64-66C3-E053-731AD00ABB73","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E5201-BC66-66C3-E053-731AD00ABB73","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"Other genomic finding","valueDescription":null,"ValueMeaning":{"publicId":"12114314","version":"1","preferredName":"Other Genome Finding","longName":"12114314v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned._The complete genomic content of an organism, and possibly the full DNA sequence of that organism. It is contained in a set of chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA or RNA molecule in viruses._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genome","conceptCode":"C16629","definition":"The complete genomic content of an organism, and possibly the full DNA sequence of that organism. It is contained in a set of chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA or RNA molecule in viruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8E5201-BC65-66C3-E053-731AD00ABB73","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8E5201-BC67-66C3-E053-731AD00ABB73","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"DUX4 rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"12114315","version":"1","preferredName":"DUX4 Gene Rearrangement","longName":"12114315v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the DUX4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DUX4 Gene Rearrangement","conceptCode":"C190878","definition":"A molecular abnormality indicating rearrangement of the DUX4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8EB38A-9F2B-79AA-E053-731AD00A3647","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8EB38A-9F30-79AA-E053-731AD00A3647","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"BCL11B rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"12114316","version":"1","preferredName":"BCL11B Gene Rearrangement","longName":"12114316v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the BCL11B gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCL11B Gene Rearrangement","conceptCode":"C186806","definition":"A molecular abnormality indicating rearrangement of the BCL11B gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8EB38A-9F2C-79AA-E053-731AD00A3647","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8EB38A-9F31-79AA-E053-731AD00A3647","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"ETV6-RUNX1-like features","valueDescription":null,"ValueMeaning":{"publicId":"12114317","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features","longName":"12114317v1.00","preferredDefinition":"B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of ETV6-RUNX1-positive B acute lymphoblastic leukemia, absence of the pathognomonic ETV6-RUNX1 rearrangement, and rearrangements or deletions of ETV6 and IKZF1 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features","conceptCode":"C190957","definition":"B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of ETV6-RUNX1-positive B acute lymphoblastic leukemia, absence of the pathognomonic ETV6-RUNX1 rearrangement, and rearrangements or deletions of ETV6 and IKZF1 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8EB38A-9F2D-79AA-E053-731AD00A3647","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8EB38A-9F32-79AA-E053-731AD00A3647","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"MEF2D rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"12114318","version":"1","preferredName":"MEF2D Gene Rearrangement","longName":"12114318v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the MEF2D gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MEF2D Gene Rearrangement","conceptCode":"C190879","definition":"A molecular abnormality indicating rearrangement of the MEF2D gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8EB38A-9F2E-79AA-E053-731AD00A3647","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8EB38A-9F33-79AA-E053-731AD00A3647","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"},{"value":"PAX5alt","valueDescription":null,"ValueMeaning":{"publicId":"12114319","version":"1","preferredName":"PAX5 Gene Alteration Positive","longName":"12114319v1.00","preferredDefinition":"A finding indicating that mutation, underexpression, overexpression, amplification or rearrangement of the PAX5 gene has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PAX5 Gene Alteration Positive","conceptCode":"C190880","definition":"A finding indicating that mutation, underexpression, overexpression, amplification or rearrangement of the PAX5 gene has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE8EB38A-9F2F-79AA-E053-731AD00A3647","latestVersionIndicator":"Yes","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE8EB38A-9F34-79AA-E053-731AD00A3647","beginDate":"2022-11-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-11-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BE7A-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"KUMMEROA","dateModified":"2022-11-29","changeDescription":"Created for TARGET CDE harmonization project. mc 4/9/2015","administrativeNotes":"2022.11.29 PVs added for ticket request CADSR0001705. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650571","version":"1","longName":"ALL","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"ALL_RP_GENE_ABN","type":"COG GDE Short Name","context":"COG"}],"ReferenceDocuments":[{"name":"ALL Molecular Subtype","type":"Preferred Question Text","description":"ALL Molecular Subtype","url":null,"context":"NCIP"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Acute lymphoblastic leukemia (ALL) molecular subtypes:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Molecular Subtype:","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Acute lymphoblastic leukemia (ALL) with known defining Genetic Abnormalities Classification type:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135EEC98-D759-84BF-E050-BB89AD436F63","latestVersionIndicator":"Yes","beginDate":"2015-04-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-10","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":"Created for TARGET harmonization project per request by T.Davidsen. mc 4/10/2015","administrativeNotes":"2023.9.7 AQT added per ticket request CADSR0002816. ak 2022.11.29 AQT added for ticket request CADSR0001705. ak","unresolvedIssues":null,"deletedIndicator":"No"}}